(Total Views: 505)
Posted On: 09/29/2025 8:47:55 AM
Post# of 157413
Re: USS JOHNSTON #157324
Quote:
it is not an unreasonable request to get some answers re: if we are or are not considering a trial revision to improve patient and drug performance outcomes.
With the new information on PD-L1, Dr. Lalezaei would have strived to change the protocol after it was approved in November 2024. It was obviously turned down by the FDA since he's now seeking a follow-up study. I have confidence in my analysis, so I don't need the Company to spoon feed me any information and piss off the FDA in the process.
(16)
(0)
